Department of Pathology and Forensic Medicine, Ribeirão Preto Medical School (FMRP/USP), University of São Paulo, Ribeirão Preto, São Paulo, Brazil.
Hematology Division, Department of Clinical Medicine, Ribeirão Preto Medical School (FMRP/USP), University of São Paulo, Ribeirão Preto, São Paulo, Brazil.
Head Neck. 2019 Dec;41(12):4111-4120. doi: 10.1002/hed.25954. Epub 2019 Sep 9.
M2 macrophages are often detected in oral squamous cell carcinoma (OSCC), which, influenced by hypoxic conditions, appear to have high angiogenesis-inducing capacity. However, the effects of immunosenescence on tumor-associated macrophages (TAMs) and angiogenesis in OSCC are unknown.
Fifty-seven OSCCs were divided into 3 groups (I: <40 years [n = 17]; II: 40-65 years [n = 20]; III: >65 years [n = 20]). Immunohistochemistry for CD68 and CD163 (TAMs), and CD34 and D2-40 for microvessel density (MVD), microvessel area (MVA), and total vascular area (TVA) were performed.
All groups showed similar clinicopathological and immunohistochemical findings. Similar CD68 and CD163 expression, confirmed a M2 phenotype. MVD, MVA, and TVA were similar, however, with significant predominance of blood vessels. No significant correlation between macrophage and angiogenic markers was observed.
A similar TAM and angiogenesis profile suggests the participation of other mechanisms, instead immunosenescence, in young and elderly OSCC patients.
M2 巨噬细胞常在口腔鳞状细胞癌(OSCC)中被检测到,受缺氧条件影响,M2 巨噬细胞似乎具有较高的血管生成诱导能力。然而,免疫衰老对 OSCC 中肿瘤相关巨噬细胞(TAMs)和血管生成的影响尚不清楚。
将 57 例 OSCC 分为 3 组(I:<40 岁[n=17];II:40-65 岁[n=20];III:>65 岁[n=20])。采用 CD68 和 CD163(TAMs)的免疫组织化学染色,以及 CD34 和 D2-40 检测微血管密度(MVD)、微血管面积(MVA)和总血管面积(TVA)。
所有组均显示出相似的临床病理和免疫组织化学发现。相似的 CD68 和 CD163 表达证实了 M2 表型。MVD、MVA 和 TVA 相似,但血管占明显优势。未观察到巨噬细胞和血管生成标志物之间存在显著相关性。
相似的 TAM 和血管生成特征表明,在年轻和老年 OSCC 患者中,免疫衰老以外的其他机制参与其中。